Moderate and High Risk Myelofibrosis
1 clinical trials · Condition
◉ Watch Moderate and High Risk Myelofibrosis
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis (NCT05020652) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-11-11 |
Track Moderate and High Risk Myelofibrosis automatically
Every clearance here is in the API, with alerts when new ones post.